Literature DB >> 6440995

Influence of lectin-free interleukin-2 on natural and antibody-dependent cellular cytotoxicity.

I Kimber, T Bakács, K Roberts, M Moore.   

Abstract

Supernatants derived from MLA-144, a gibbon T cell line that constitutively releases interleukin-2 (IL-2) and which lack detectable interferon (IFN) had the capacity to enhance the natural killer (NK) cells function of human peripheral blood lymphocytes. Percoll fractionation revealed that like IFN-inducible cytotoxic cells lymphocytes responding to MLA-144 supernatants cofractionate with native NK cells. Exposure to MLA-144 conditioned medium also potentiated the cytotoxic capacity of extravascular effector cells which are either unresponsive or weakly responsive to interferon-alpha (IFN-alpha). Moreover lymphocyte (K cell)-mediated antibody-dependent cellular cytotoxicity (ADCC) which is unresponsive to IFN-alpha was in most cases subject to a modest potentiation following treatment with MLA-144 supernatants. These data confirm previous reports that IL-2 can regulate peripheral blood NK cell function and also demonstrate that this lymphokine can also influence those natural cytotoxic mechanisms which are unresponsive to IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440995

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  3 in total

1.  Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets.

Authors:  M Ito; S Bandyopadhyay; M Matsumoto-Kobayashi; S C Clark; D Miller; S E Starr
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

2.  Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.

Authors:  S Bandyopadhyay; D S Miller; M Matsumoto-Kobayashi; S C Clark; S E Starr
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

3.  Independence of depressed lectin-dependent cell-mediated cytotoxicity from interleukin 2 production in patients with systemic lupus erythematosus.

Authors:  A Perl; R González-Cabello; K Onody; I Bodó; P Gergely
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.